Our Team

Lee Blansett has been an active participant in the US healthcare system for more than 20 years. His research into health system organizations and oncology market access topics includes extensive on-the-ground studies in the US and EU. Lee’s previous work includes internal consulting roles with APM, Kaiser Permanente, Stanford Children’s Hospital, and a community oncology group. His work on manufacturers’ behalf includes serving as a Senior Vice President at DaVinci Oncology/Kantar and as a Senior Principal with the IMS Consulting Group. His academic training includes an MBA from the Wharton School and a BSC in finance from Santa Clara University, where he was a National Merit Scholar. 

Cindy Chen oversees HMP Market Access Insights’ quantitative research initiatives in oncology and assists with our clinical evidence initiative, exploring payer data requirements for coverage of gene therapies and other products addressing rare diseases. Cindy has worked with multiple global life sciences companies while at Strategic Decisions Group, IMS Consulting Group, and as an independent consultant. She has helped pharmaceutical companies evaluate development strategies for pipeline candidates, supported long-term strategic planning, and optimized portfolios of development and in-market franchises. Cindy holds an MBA from the Wharton School of Business, a bachelor’s in business administration from the Haas School at UC Berkeley and is a Certified Public Accountant.

Chris Van Denburg’s career focuses entirely on studying the healthcare system and its adoption of novel treatments. His work over the last two decades has covered the spectrum of market access, including roles in market research, data analytics, marketing, pricing and contracting, operations, training, special pharmacy partnership programs, and patient support services. His corporate experience includes both large and small biopharmaceutical companies, in addition to serving as an external consultant to several companies.

Chris holds a bachelor's degree from Ithaca College, and has direct oncology laboratory and clinical research experience at the Strang-Cornell Cancer Research Laboratory and Strang Cancer Prevention Center.

Taylor Crutison is a Senior Consultant at HMP Market Access Insights who focuses on primary and secondary research and data analysis. Her interest in oncology began at Dana-Farber Cancer Institute, where she engaged with patients to assess readiness for digital health tools and identified improvement areas in Dana-Farber’s patient reported outcomes data collection system. Additionally, her previous provider experiences include internships at Kaiser Permanente and a small community health nonprofit.

Taylor holds an MPH from Columbia University’s Mailman School of Public Health, where her studies focused on health policy and management, and a bachelor’s degree in human biology from Stanford University.